Upgrade to SI Premium - Free Trial

Amphastar Pharmaceuticals (AMPH) PT Lowered to $22 at Needham & Company

August 9, 2018 1:38 PM
Needham & Company lowered its price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $22.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles